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T-2 toxin is known to be one of the most toxic trichothecene mycotoxins. Exposure to T-2 toxin induces many
hematologic and immunotoxic disorders and is involved in immuno-modulation of the innate immune response.
The objective of this work was to evaluate the effects of T-2 toxin on the activation of macrophages by different
agonists of Toll-like receptors (TLR) using an in vitro model of primary porcine alveolar macrophages (PAM).
Cytotoxic effects of T-2 toxin on PAM were first evaluated. An IC50 of 19.47 ± 0.9753 nM was determined for the
cytotoxicity of T-2 toxin. A working concentration of 3 nM of T-2 toxin was chosen to test the effect of T-2 toxin on
TLR activation; this dose was not cytotoxic and did not induce apoptosis as demonstrated by Annexin/PI staining. A
pre-exposure of macrophages to 3 nM of T-2 toxin decreased the production of inflammatory mediators (IL-1 beta,
TNF-alpha, nitric oxide) in response to LPS and FSL1, TLR4 and TLR2/6 agonists respectively. The decrease of the
pro-inflammatory response is associated with a decrease of TLR mRNA expression. By contrast, the activation of
TLR7 by ssRNA was not modulated by T-2 toxin pre-treatment. In conclusion, our results suggest that ingestion of
low concentrations of T-2 toxin affects the TLR activation by decreasing pattern recognition of pathogens and thus
interferes with initiation of inflammatory immune response against bacteria and viruses. Consequently, mycotoxins
could increase the susceptibility of humans and animals to infectious diseases.Introduction
The Food and Agricultural Organization (FAO) estimates
that mycotoxins, secondary metabolites produced by
fungi, contaminate 25% of the world’s agricultural
commodities. The presence of mycotoxins alters the
quality of agricultural products resulting in economical
losses estimated in billions dollars annually worldwide
[1,2]. The consumption of food and feed contaminated
by mycotoxins is a potential health hazard for both
humans and animals [3,4]. Among mycotoxins, T-2 toxin
is the most common trichothecene mycotoxin belonging
to type A and is produced predominantly by Fusarium
sporotrichioïdes and F. langsethiae [4,5]. This toxin is
known to be the most cytotoxic of the trichothecene
family [6]. An exposure of T-2 toxin is associated with* Correspondence: Isabelle.Oswald@toulouse.inra.fr; laurence.guzylack@
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reproduction in any medium, provided the orleucopenia and cell depletion in lymphoid organs and
inhibition of erythropoiesis in bone marrow and the
spleen [7]. Furthermore, T-2 toxin reduces lymphocyte
proliferative response [8,9] and disturbs the maturation
process of dendritic cells [10] suggesting its immunosup-
pressant potency [7,11]. Indeed, it was previously shown
that exposure to T-2 suppresses immune response to
systemic infections by bacterial infection such as
Salmonella typhimurium [12], Listeria monocytogenes
[13], Mycobacterium bovis [13], Babesia microti [14].
Respiratory immune defences are also compromised by
T-2 exposure. Indeed Li et al. [15] showed that systemic
T-2 exposure increases the severity of respiratory
reovirus infection with marked exacerbation of broncho-
pneumonia and modulation of cytokine responses in
mice alveolar macrophages.
Among other species, swine react most sensitively to
the exposure to trichothecenes [16]. Pigs are particularly. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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diet rich in cereals and because the pig shares strong
similarities with the human immune system [17].
Moreover, swine are the target of several pathogenic
agents responsible for many respiratory diseases such as
Influenza virus, porcine reproductive and respiratory
syndromes (SPRD), or bacteria as Haemophilus parasuis.
Then, mycotoxins, especially T-2 toxin, could play a
determining role in lowering the immune response of
pigs to these bacterial and viral infections.
Macrophages play a key role in the immune response
being the first cells to be exposed to microorganisms.
These cells are considered as sentinel cells against infec-
tious pathogens and involved in phagocytosis, antigen
presentation, production of antimicrobial effector
molecules and release of cytokines and chemokines that
in turn contribute to immune cell recruitment and
activation [18-20]. The recognition of microorganisms by
macrophages occurs through a major receptor family
expressed in distinct cell subsets and tissues called the
Toll-Like Receptors (TLR) [21-23]. They are able to bind
to a wide range of motifs derived from bacteria (lipopoly-
saccharide (LPS), peptidoglycan), parasites, fungi and
viruses (ssRNA, dsRNA, CpG DNA) [21,24]. Interaction
of TLR with its specific ligands leads to the induction
of various inflammatory cytokines such as IL-1β and
TNF-α [25] and reactive nitrogen species [26]. This pro-
inflammatory response is the first line of defence against
infections.
Since macrophages are privileged targets of T-2 toxin
[10,27,28], it is important to better understand how this
toxin can impair their function. In the current study, we
investigated the effect of T-2 toxin on macrophage
activation. We especially measured the ability of T-2
toxin to inhibit the production of inflammation media-
tors upon TLR activation as well as the effect of this
toxin on TLR gene expression.
Materials and methods
Isolation, phenotype and culture of macrophages
Porcine alveolar macrophages (PAM) from 6- to 8-
week-old pigs were isolated by three time bronchoal-
veolar lavages using cold PBS (Invitrogen, Auckland,
NZ). Bronchoalveolar fluids were centrifuged at 400 g
for 15 min at 4°C and cell viability was assessed using
Trypan blue exclusion. Next, the cells were frozen in li-
quid nitrogen in 90% FBS and 10% DMSO. After thaw-
ing, the cells were adjusted to a cell concentration of
2 × 106 cells/mL in RPMI (Invitrogen) supplemented
with 10% FBS, 1% penicillin-streptomycin (Invitrogen),
1% non essential amino acid (Sigma Aldrich, Ayshire,
UK) and 1% L-glutamin (Eurobio, Courtaboeuf, France).
The phenotypic identification of PAM was realized by
analyzing the expression of differentiation or maturationmarkers: SWC1, SWC3, CD14, CD16, CD163, MHCII
and DC-sign. Anti-SWC1 IgM 11-305-44 and rabbit-DC-
sign antibodies were a kind gift from Dr A. Saalmüller
(Veterinary University Vienna, Austria) and Dr M. Meng
(College of veterinary medicine, Virginia, USA).
Respectively, anti-rabbit-FITC antibody was obtained by
Invitrogen. Anti-SWC3 antibodies (clones 74-22-15A and
74-22-15), CD14 (CAM36A), CD16 (G7) and MHCII
(MSA3) were commercialised by VMRD (Pullman, USA).
CD163 antibody (clone EDHu-1) was purchased from
AbD Serotec (Oxford, UK). CD206 (clone 122D2.08) was
commercialized by dendritics (Lyon, France). Reaction of
all mAbs was revealed using isotype specific FITC,
phycoerythrin, or biotinylated IgG F(ab)’2 fragments.
Biotinylated conjugates were detected with streptavidin-
Cy5-phycoerythrin. All conjugates were purchased from
Southern Biotechnology Associates (Birmingham, USA).
A negative control containing only conjugated-antibodies
was used to visualise a non specific labelling.
PAM were incubated with different doses of T-2 toxin
(Sigma Aldrich) for 1 h at 39°C in a humidified atmos-
phere with 5% CO2 and were activated by different
specific TLR-agonists during 16 h at 39°C. Indeed, 39°C is
the physiological temperature for pigs. Preliminary
experiments indicate an optimal production of
cytokines by PAM after 16 h of culture in contact with
TLR-agonists. TLR-agonists were used with the following
concentrations: TLR2-L (HKLM) [10 μg/mL], TLR4-L
(LPS) [10 μg/mL], TLR2/6-L (FSL1) [1 μg/mL] and
TLR7-L (Imiquimod) [10 μg/mL] (Invivogen, Toulouse,
France). The negative control was a dilution of DMSO
solution (vehicle of T-2 toxin) used at the higher concen-
tration of T-2 toxin tested in the experiments. As a posi-
tive control of PAM activation, cells were stimulated with
a combination of LPS [5 μg/mL] (Sigma Aldrich) and
IFN-γ [1 ng/mL] (Biosource International, Camarillo,
USA). After 4 h of activation, cells were isolated to inves-
tigate mRNA expression by quantitative real-time PCR
analysis. After 16 h of activation, cells were harvested to
evaluate the nitric oxide production and culture super-
natant were also collected for pro-inflammatory cytokine
analysis.
Cytotoxicity, mitochondrial transmembrane potential and
apoptosis assays
Cytotoxicity of T-2 toxin on PAM was measured by Cell-
Titer-Glo luminescent cell viability assay (Promega,
Madison, USA). This test is based on the quantification
of the ATP assumed to be produced by metabolically
active viable cells. It was used according to the manufac-
turer’s protocol. PAM were treated during 16 h at 39°C
with different concentrations of T-2 toxin: 0.3; 1; 3; 10;
30 and 100 nM. A negative control using cells without
T-2 toxin treatment was in correspondence to 100% of
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cate and repeats on cells came from three different pig-
lets. IC50 was determined with SigmaPlot software for
windows version 11.0 (Systat software Inc., Chicago,
USA).
For mitochondrial transmembrane potential (ΔΨm)
measurement, cells were treated for 16 h with the same
range of T-2 toxin concentrations as previously described.
DIOC6 probe obtained by Invitrogen was added to 100 μL
of cell suspension and was incubated at 39°C for 20 min.
ΔΨm was analyzed by flow cytometry with excitation at
488 nm. A negative control without T-2 toxin and a posi-
tive control, FCCP (Carbonyl cyanid 4-trifluoromethoxy-
phenylhydrasone, Enzo Life Sciences,Villeurbanne, France)
at 40 mM were used to determine fluctuation of ΔΨm.
Apoptosis was determined by AlexaFluor488-AnnexinV/
Death cell apoptosis kit (Invitrogen). The cells were col-
lected, and 2× 106 cells per mL were resuspended in PBS-
1X (pH 7.4) and incubated with AlexaFluor488annexin-V
and propidium iodide (PI). The staining was realized
according to the manufacturer’s recommendation.
Flow cytometric acquisition was performed on a flow
cytometer (FACS Calibur, Becton Dickinson, Franklin
Lakes, NJ, USA) using CellQuest software (Becton
Dickinson) and FlowJo software for analysis (Ashland,
USA).
IL-1β and TNF-α cytokine assays
Concentrations of IL-1β and TNF-α were measured by
enzyme linked immuno-absorbent assays (ELISA) using
kits specific for porcine IL-1β and TNF-α (R&D Systems,
Minneapolis, MN, USA). The plates were washed with
PBS/Tw20 and then blocked with PBS containing 1%
BSA (w/v) for 1 h at RT. The test supernatants were
added to the ELISA plate in duplicate and incubated for
2 h at RT. After washing, the wells were incubated with
the biotinylated detection anti-porcine TNF-α/TNFSF1A
and anti-porcine IL-1β/IL-1 F2 (R&D Systems) anti-
bodies for 2 h at RT. Then, streptavidin-HRP-conjugated
antibody (Thermo Fisher Scientific, Courtaboeuf, France)
was added for 30 min at RT. Positive reactions were
revealed by TMB, a colour substrate (Thermo Fisher
Scientific) and reactions were stopped with H2SO4 2 N.
The OD was read at 450 nm. A negative control was in
correspondence to non-activated TLR-agonist cells and
as a positive control, cells were stimulated with a
combination of LPS [5 μg/mL] and IFN-γ [1 ng/mL].
Concentrations obtained in negative control wells were
subtracted from the values in treated samples.
Nitric oxide assay
Nitric oxide measurement was performed by DAF-FM
diacetate (4-amino-5-methylamino-2′,7′-difluorofluores-
cein diacetate) probe. The probe used a non-fluorescentreactive base able to react to low doses of nitric oxide
forming a fluorescent compound which is detectable by
flow cytometry. DAF-FM was used at 10 μM according
to the manufacturer’s protocol (Invitrogen). After DAF-
FM addition, PAM were incubated at 39°C for 30 min then
washed twice with PBS. Cells were incubated another time
during 15 min at 39°C to allow a complete esterification of
intracellular diacetate and the cell fluorescence emission
producing nitric oxide were analyzed by flow cytometry. A
negative control was in correspondence to non-activated
TLR-agonist cells and as a positive control cells were sti-
mulated with a combination of LPS [5 μg/mL] and IFN-γ
[1 ng/mL]. Concentrations obtained in the negative con-
trol, including no T-2 toxin and no stimulation with any
TLR agonist treatments were subtracted from the values
obtained with treated cells.
RNA extraction and quantitative real-time polymerase
chain reaction (PCR) analysis
Quantitative real-time PCR was performed to determine
the relative TLR −2, -4, -2/6, -7 and iNOS (inducible
Nitric Oxide Synthase) mRNA expression levels. Total
RNA from 2× 106 cells/mL unstimulated cells and
2 × 106 cells/mL ligand-stimulated cells in the presence
or absence of T-2 toxin was extracted with TRIzol
Reagent (Extract all, Eurobio). Concentrations, integrity
and quality of RNA were determined spectrophotomet-
rically (O.D.260) using Nanodrop ND1000 (Labtech
International, Paris, France). Then, 300 ng of RNA was
reverse transcribed and the reverse transcription and
real-time PCR steps were performed as previously
described [29]. Non-reverse transcribed RNA was used
as the non-template control for verification of a no
genomic DNA amplification signal. Specificity of PCR
products was assessed at the end of the reaction by
analyzing the curve of dissociation. Primers were
purchased from Invitrogen. Primers used for real time
quantitative polymerase chain reaction are described in
Table 1 [30-34]. Amplification efficiency and initial fluor-
escence were determined by the DART-PCR method,
then the values obtained were normalized with house-
keeping genes, ribosomal protein L32 (RPL32) and
beta2-microglobulin. Finally, relative gene expression
was expressed in comparison to the control culture
corresponding to unstimulated cells.
Statistics
A Fisher’s test was realized followed by the Student’s t-
test to compare values between multiple groups. The
statistical analysis of the data was carried out with
Statview software (Statistical Analysis System; SAS for
Windows 98; SAS Institute Inc., Cary, NC, USA). A P
value of less than 0.05 was considered to be statistically
significant.
Table 1 Primers used for real time quantitative polymerase chain reaction. List of gene sequences and primers (For:
Forward; Rev: Reverse) used for real-time qPCR of immune-related genes
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Phenotypic characterization of primary porcine alveolar
macrophage cells (PAM)
The specific staining with different markers confirmed that
more than 95% of the cultured cells were PAM displaying
the following phenotypes: SWC3high, SWC1+, CD163high,
CD14-, CD16+, MHCII+ and DC-sign+ (Additional file 1:
Figure S1).
Cytotoxicity effects of T-2 treatment on PAM
A dose-dependent effect of T-2 toxin on cell viability was
demonstrated by measuring the cellular ATP level after ex-
posing PAM to increasing concentrations of the toxin (Fig-
ure 1a). T-2 toxin did not induce a cytotoxic effect on PAM
from 0.3 to 3 nM while exposure to 10 nM of T-2 toxin
reduced the ATP level to 82% compared to the untreated
cells. At 30 nM, T-2 toxin induced a dramatic drop of cell
viability leading to only 31.4% of ATP level compared to the
control. IC50 value deducted from the dose–response curve
was estimated at 19.47 nM +/− 0.9753 nM.
To determine if the loss of cell viability is a consequence of
an apoptotic process, the identification of early apoptotic cells
was measured using FITC-annexinV reagent in conjunction
with a vital dye, propidium iodide (PI). T-2 toxin (<10 nM)
did not induce apoptosis (Figure 1b). Only concentrations
over 30 nM produced a significant increase of Annexin+/PI-
cells (14%), revealing apoptosis of macrophages.
Apoptosis is associated with a loss of mitochondrial
membrane potential (Δψm). To confirm the loss of via-
bility induced by T-2 toxin (Figure 1a and b), a DIOC6
staining which is a mitochondrial-specific and voltage-
dependent dye was carried out (Figure 1c). As expected,
treatment by FCCP, a potent reversible inhibitor of mito-
chondrial oxidative phosphorylation, used as a positive
control, induced a significant decrease of 41.6% of the
DIOC6 signal. From 0.3 to 10 nM, T-2 toxin did not
affect Δψm, while 30 nM of T-2 toxin significantlyreduced Δψm of PAM (63.6% of MFI compared to the
control). Thus, DIOC6 staining results confirmed the in-
duction of the apoptosis by high dose of T-2 toxin and
demonstrated the similar dose–response regarding ATP
level and mitochondrial membrane potential. Based on
these results, a concentration of 3 nM was chosen for
the following studies.Alteration of macrophage activation by T-2 toxin
To investigate the effects of T-2 toxin on macrophage
activation, the cells were exposed for 1 h to 3 nM of T-2
toxin before being treated with different TLR-agonists
during 16 h (TLR2, TLR4, TLR2/6 and TLR7 agonists).
Two cytokines involved in the inflammation process
were measured to determine the macrophage activation
status: IL-1β and TNF-α. The positive control (combin-
ation of LPS and IFN-γ) led to high production of both
IL-1β and TNF-α, at levels similar to those found
with TLR4 agonist (Figure 2a and b). Basal levels of both
IL-1β and TNF-α concentrations obtained in the nega-
tive control including neither T-2 toxin nor stimulation
with TLR-agonists were set off. However, cytokine levels
were different depending on the nature of TLR-agonists,
demonstrating a specific ability of each TLR-agonist to
induce a particular level of cytokine responses in PAM.
In particular, TLR2, TLR2/6 and TLR7 agonists seem to
induce lower production of TNF-α compared to TLR4
and IFN-γ/LPS (Figure 2b).
Pre-exposure to 3 nM of T-2 toxin significantly
decreased both IL-1β and TNF-α induced by TLR2/6
agonist (50.4% and 55.9% reduction of production
respectively) and only a significant decrease of IL-1β
induced by TLR4 agonist (55.6%). Interestingly, pre-
treatment with T-2 toxin did not affect the production of
IL-1β and TNF-α cytokines in response to TLR7-agonist
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Figure 1 Cell viability and apoptosis induced by T-2 toxin in porcine alveolar macrophages (PAM). A-Decrease of cell viability in PAM
treated with different T-2 toxin concentrations. PAM cultures were exposed to 0.3–100 nM of T-2 toxin for 16 h. Cell viability was assessed by
measurement of ATP release. B- Increase of apoptosis in PAM as a function of different T-2 toxin concentrations. PAM cultures were exposed to 0.3
to 30 nM of T-2 toxin. Apoptotic cells were analyzed by flow cytometry using a double staining AnnexinV/IP. C- Decrease of mitochondrial
membrane potential (Δψm) in PAM treated with T-2 increasing toxin concentrations. PAM cultures were exposed to 0.3 to 30 nM of T-2 toxin,
followed by flow cytometry analysis of DIOC6 probe. A positive control, FCCP (Carbonyl cyanide 4-(trifluoromethoxylphenylhydrazone)) was used to
establish a loss of mitochondrial membrane potential (Δψm). All data were reported to the negative control including only the vehicle (0-DMSO),
used as 100% of cell viability. Data are shown as mean +/− SEM with PAM from three different piglets are shown and were performed in triplicate.
* indicates a P value< 0.05.
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production induced by macrophage activation after T-2
toxin treatment
Nitric oxide (NO) production plays an important role in the
protection against intracellular microbiostasis. NO, produced
by macrophages in response to specific stimuli is catalyzed
by inducible Nitric Oxide Synthase (iNOS). Relative gene ex-
pression of iNOS was assessed by quantitative real time PCR
(Figure 3a). As expected, TLR-agonists induced a significant
increase of iNOS expression. By contrast, pre-treatment
with T-2 toxin abrogated expression of iNOS induced by all
TLR-agonists used. Relative gene expression of iNOS was
closer than the expression of negative controls. To confirmthese results,the inhibition of NO production in activated
PAM by a T-2 toxin pre-treatment was investigated. The
production of NO was measured by flow cytometry,
using the DAF-FM probe (Figure 3b). As observed for
pro-inflammatory cytokines, IFN-γ/LPS combination as
well as TLR-agonist stimulation led to NO production
by macrophages, thereby confirming the activation
process. However, T-2 pre-treatment did not seem to
affect production of NO by IFN-γ/LPS co-stimulation.
In addition, T-2 toxin pre-treatment significantly decreased
to 100 and 72.5% the NO production after activation by
TLR4 and TLR2/6 agonists respectively. T-2 toxin pre-ex-
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Figure 2 Concentration of IL-1β and TNF-α in supernatants of PAM pre-incubated with T-2 toxin. Cells were cultured for 1 h in the presence
(black bars) or absence (white bars) of 3 nM of T-2 toxin before their activation with different TLR-agonists: TLR2-agonist (HKLM=10 μg/mL); TLR4-agonist
(LPS=10 μg/mL); TLR2/6-agonist (FSL1=1 μg/mL) and TLR7-agonist (Imiquimod=10 μg/mL) for 16 h. IL-1β (A) and TNF-α (B) concentrations were
determined by ELISA in PAM culture supernatants. Concentrations obtained in negative controls (vehicle) were subtracted from concentration values in
treated samples. The mean (+/− SEM) of the values obtained with PAM from five different piglets are shown. * indicates a P value< 0.05.
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both TLR2 and −7 (69.8 and 49.0% reduction of produc-
tion). These data suggest that T-2 treatment alters the im-
plementation of pro-inflammatory response which is
initiated by TLR-agonists. Transcriptomic data of iNOS
gene expression could partially explain the decrease of NO
production by porcine alveolar macrophages observed
with DAF-FM staining.
Effects of T-2 toxin on mRNA expression of TLR
To understand the decrease of the pro-inflammatory
response, the effect of T-2 toxin on the mRNA expression of
specific TLR was evaluated. As expected, treatment of PAM
by specific TLR-agonists, led to significant increase in relative
mRNA expression of specific TLR (Table 2). It is worth men-
tioning that T-2 pre-exposure did not lead to a complete in-
hibition of the mRNA expression. However, a pre-incubation
with 3 nM of T-2 toxin before activation induced a significant
decrease of 60.1%, 64.3% and 68.8% of relative expression of
TLR2, TLR4 and TLR2/6 mRNA expression respectively
(Table 2). Remarkably, T-2 toxin did not significantly reduce
mRNA expression of TLR7.
Effects of T-2 toxin on the expression of cell surface
receptors of macrophages
In order to examine the specificity of action of T-2 toxin
on cell surface receptors, we analyzed the expressionby flow cytometry of two receptors, namely CD14 (co-re-
ceptor with the TLR4 for the detection of bacterial LPS)
and CD206 (macrophage mannose receptor) present on the
cell surface, after treatment with T-2 toxin (Figure 4). Sur-
prisingly and in contrast to the T-2 toxin action observed
on TLR expression, the expression level of both receptors
was not affected by the presence of T-2 toxin (Figure 4).
Moreover, TLR-agonist stimulation did not induce an in-
crease of expression of these two cell surface markers.
Discussion
Pigs are preferential targets of many respiratory diseases
caused by bacteria such as Pasteurella multocida [35].
Different swine respiratory viruses such as African swine
fever virus (ASFV) [36] or porcine reproductive and re-
spiratory syndrome virus (PRRSV) [37] also target alveolar
macrophages for their replication. It is well established that
when incorporated in feed or given in daily doses, T-2 toxin
decreases resistance against viral or bacterial infections
[12,15]. Moreover, Ziprin et al. [13] showed that the T-2
toxin effect on the course of in vivo bacterial infection
depends on the nature of the infectious agent. Based on
these different data, the present study is of further interest
to address whether T-2 toxin can similarly reduce immune
resistance depending on the nature and composition of
microbial pathogens, using TLR4 and TLR6-agonists, struc-
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Figure 3 Analysis of relative expression of iNOS mRNA (A) and nitric oxide (NO) production (B) in PAM pre-treated with T-2 toxin.
A- T-2 toxin affects iNOS mRNA expression: Relative mRNA expression of iNOS in PAM treated or not by 3 nM of T-2 toxin for 1 h before
their activation with each specific TLR-agonist during 4 h. Data were analyzed with DART-PCR software and iNOS expression was
normalized by the mean of two housekeeping genes (β2-microglobuline and RPL32). Gene expression of iNOS was reported to
unstimulated PAM whose expression is visualized by the line level at 1. Significant differences (P< 0.05) between unstimulated PAM
(negative control) and cells treated (with TLR-agonists in the absence or presence of T-2) are marked with an asterisk. B- T-2 toxin affects
NO production: the cells were cultured for 1 h in the presence (black bars) or absence (white bars) of 3 nM of T-2 toxin before their
activation with different TLR-agonists: TLR2-agonist (HKLM); TLR4-agonist (LPS); TLR2/6-agonist (FSL1) and TLR7-agonist (Imiquimod) for
16 h. An incubation of both cells and DAF-FM probe was used to determine the production of NO. Mean Fluorescence Intensity (MFI) of
DAF-FM +/− SEM was determined by flow cytometry analysis and then normalized with the negative control. Mean (+/− SEM) of values
obtained with PAM from five different piglets are shown. * indicates a P value< 0.05.
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implemented by alveolar macrophages is impaired by T-
2 toxin. T-2 toxin is known to be cytotoxic and to induce
apoptosis on immune cells like human monocytes,
human dendritic cells and human and rat macrophagesTable 2 Relative mRNA expression of TLR (−2, -4, -2/6 and −7
negative control
HKLM (TLR2-L) 1 +/− 0.14
LPS (TLR4-L) 1 +/− 0.11
FSL1 (TLR2/6-L) 1 +/− 0.22
Imiquimod (TLR7-L) 1 +/− 0.20
Primary porcine cells (2 × 106 cells per mL) were exposed or not with 3 nM of T-2
TLR2-agonist (HKLM); TLR4-agonist (LPS); TLR2/6-agonist (FSL1) and TLR7-agonist
quantitative real time PCR. Data were analyzed by DART-PCR software and gene
and β2-microglobuline). TLR gene expression was reported to unstimulated PAM
ANOVA test, Student test was conducted to determine the differences among gr
different piglets are shown. Significant differences (P< 0.05) between unstimulat
an asterisk (*). Significant differences (P< 0.05) between TLR-L-activated cells in[10,28,38,39]. We observed that after 16 h exposure to
T-2 toxin, the cell viability of PAM is affected by 10 nM
of T-2 toxin and the IC50 value was evaluated near 20
nM. This concentration was in accordance with other
studies on immune cells [10,40]. Cell death may be due) after T-2 toxin treatment in PAM
TLR-L T-2 + TLR-L
76.92 +/− 16.67* 29.08 +/− 8.16 (*), (t)
17.69 +/− 4.80* 6.32 +/− 1.46 (*), (t)
259.90 +/− 75.91* 81.07 +/− 15.62 (*), (t)
13.66 +/− 3.92* 7.03 +/− 1.66 (*)
toxin for 1 h before activation during 4 h at 39°C by different TLR-agonists:
(Imiquimod). Relative expression of TLR genes was evaluated by
expression was normalized by the mean of two housekeeping genes (RPL32
. After checking for the normal distribution of data carried out with one-way
oups. The mean (+/− SEM) of the values obtained with PAM from five
ed cells (negative control) and cells treated by each TLR-L are marked with
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Figure 4 Effects of T-2 toxin on the expression of both cell surface receptor on macrophage: TLR4 co-receptor (CD14) and mannose
receptor (CD206). Cells were cultured or not for 1 h in the presence (black bars) or absence (white bars) of 3 nM of T-2 toxin before their
activation with different TLR-agonists: TLR2-agonist (HKLM); TLR4-agonist (LPS); TLR2/6-agonist (FSL1) and TLR7-agonist (Imiquimod) for 16 h at 39°
C, 5% CO2. Cells were collected and CD14 (A) and CD206 (B) staining were analyzed by flow cytometry. The mean of fluorescence intensity of
both of these two markers was normalized to the negative control. Mean (+/− SEM) of values obtained with PAM from five different piglets are
shown. * indicates a P value< 0.05
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induce the apoptosis pathway at varying concentrations
depending on the targeted cells [38,39,41,42]. For
example, in primary culture cells of hematopoietic
progenitors, T-2 toxin induces apoptosis after 3 h of in-
cubation with 10 nM of the toxin and a maximum
reached at 12 h [43] while in macrophage cell lines
(RAW 267.7), T-2 toxin induces less than 5% of apop-
totic cells after 6 h of incubation with 5 nM of T-2 toxin
[44]. The latter results are comparable to our data. A
significant induction of apoptosis was shown with the
exposure of 30 nM of T-2 toxin on PAM after 16 h of
treatment. In order to avoid possible adverse effects due
to cytotoxic and apoptotic process, a non cytotoxic and
non apoptotic concentration of 3 nM of T-2 toxin was
used for PAM activation studies. Moreover, the dose of 3
nM of T-2 toxin was relevant as a low dose and close
to the provisional tolerable daily intake (TDI) of 100 ng /
Kg bw / d [4].
Activated macrophages are the primary source of pro-
inflammatory cytokines, including IL-1β and TNF-α[27,45]. Production of these two cytokines, in response
to TLR-agonists and notably LPS, could be observed in
the present study. Interestingly, after pre-treatment with
low doses of T-2 toxin, a reduction of pro-inflammatory
cytokine concentrations appeared dependent on the
nature of the TLR-agonists. The IL-1β production was
reduced after activation by the TLR2-agonist and
significantly decreased after TLR4- and TLR6-agonist
activation. By contrast, we did not observe a reduction of
IL-1β production after activation of Pathogen Associated
Molecular Patterns (PAM) by the TLR7-agonist. Similar
results were observed regarding TNF-α response.
TLR expressed on antigen presenting cells (APC) such
as macrophages, are critical for recognition of the PAMP
on microorganisms and their abilities to induce appro-
priate immune responses. Extensive research on TLR has
been performed in humans and rodents while only a few
studies on porcine TLR have been completed. However,
most of the studies on swine TLR have clearly demon-
strated a correlation between the expression levels of
TLR2 and TLR9 expressed in several tissues (lung, heart,
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the first stages of life and the capacity for newborn
piglets to have an early efficient immune function
[46,47]. Moreover, similar distribution of TLR on human
and swine cells, unlike rodents, has been previously
described [48]. Human alveolar macrophages have low
TLR2 expression leading to a low production of TNF-α
and IL-6 cytokines [49]. Similarly, the TLR2 expression
level measured in human bronchoalveolar cells by Juarez
et al. [49] could explain the low TNF-α protein concen-
tration obtained in response to the TLR2-agonist in this
study.
It is known that activation of macrophages by agonists,
such as LPS, triggers the enhancement of expression of
iNOS leading to NO production [26]. In the present
investigation, a T-2 toxin pre-treatment induced a signifi-
cant decrease of NO production in PAM activated by
TLR4 and TLR2/6 agonists. However, this toxin did not
affect NO production after activation of macrophages by
either IFN-γ/LPS or TLR2 and −7 agonists. DON and
nivalenol also affect the immune response by inhibiting
NO production in mice macrophage cell lines in vitro
(RAW264) [50]. In addition, this study demonstrated
that there is a parallel between the decreasing of NO
production and the decreasing of iNOS mRNA gene
expression which could partially explain the effect of T-2
toxin on NO production.
Taken together, these results demonstrate the
complexity of mycotoxin action depending on the cell
activation status and mycotoxin doses. The TLR agonist-
sensitized macrophage responds to subsequent toxin
challenge with a robust and potentiated cytokine
response. By contrast, our study showed that T-2 toxin
pre-exposure inhibited naive macrophage to initiate an
inflammatory response to TLR-ligands. This inhibition
could be attributed to a defect of pathogen pattern rec-
ognition due to a T-2 toxin effect on TLR2, -4 and −2/6
expression. Due to a lack of commercially available
antibodies for pigs, we could not verify the cell surface
expression of these TLR. However, the present study
showed that the importance of this inhibition seems to
depend on the nature of the TLR. Indeed, the expression
of TLR7 mRNA seemed less affected by the toxin. These
results were consistent with the less inhibitory effect of
T-2 toxin on the inflammatory response when PAM were
activated by TLR7-agonist. This one is specifically
located on the endosomal membrane and could explain
that a T-2 toxin pre-exposure did not appear to disrupt
the pro-inflammatory response.
The alteration of TLR expression could possibly
influence the functions and efficacy of alveolar macro-
phages in terms of antigen processing and release of
cytokines. It is tempting to speculate that the sensitized
macrophage phenotype depends on both appropriatesurface TLR expressions enabling the recognition of
pathogen motifs and the appropriate induction of the
cytokine signaling pathway. However, the effects of T-2
toxin seem to be TLR-receptor specific since neither co-
receptor CD14 nor mannose receptor (CD206) were
affected by the toxin. Our group has already shown in a
previous study that DON can also inhibit cell surface
expression of activation markers of human macrophages
such as CD14, CD54, CD119 and HLA-DR [51].
Trichothecenes have the ability to modulate immune
function by disrupting intracellular signaling pathways
within leukocytes responsible for driving both altered
immune-regulatory gene expression as well as apoptosis
[52]. A review by Pestka et al. [53] demonstrated the
preferential targeting of DON on the activation of mitogen-
activated protein kinases (MAPK), thereby leading to the
modulation of immune responses and apoptosis [53]. In
addition to specific intracellular localization of TLR7, the
absence of T-2 toxin action on immune responses after
TLR7 agonists activation can be explained by focusing on
the specificity of TLR7-signaling pathways. In contrast to
other TLR which involved both MAPK and canonical IKK
complex for the transcription of inflammatory cytokine
genes, TLR7 agonist activates only the IKKα signaling path-
way to induce inflammatory cytokines [21].
Based on our finding that the T-2 toxin down-regulated
the activation of TLR, it could be hypothesized that expos-
ure to low concentrations of T-2 toxin may increase the
susceptibility of humans and animals to opportunistic
infections. The present study sheds new light on the
potential of mycotoxins to interfere with the immune
system by decreasing the expression pattern recognition of
pathogens, and thus the initiation of immune responses
against bacterial and viral infections. These results may
help to explain the immunosuppressive effect of T-2 toxin
observed in vivo during viral respiratory infection such as
reovirus [15].
Given that food and feed are sometimes contaminated
by T-2 and other trichothecenes, serious questions
remain regarding risks from chronic ingestion of these
toxins. Understanding the molecular mode of action of a
mycotoxin can assist in predicting potential adverse
human and animal health effects.
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three independent experiments.
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